Approval · Notice of Compliance 22348 · 2019
TELMISARTAN: Notice of Compliance 22348
Issued June 28, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22348
- Date
- June 28, 2019
- Company
- Sanis Health Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Labelling Only
- Reason
- Update to product monograph and labelling update (to match licensor)
- Canadian reference product
- MICARDIS (Boehringer Ingelheim (Canada) Ltd.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TELMISARTAN | Not yet assigned | — |
Medicinal ingredients
- TELMISARTAN 40 MG per TAB
- TELMISARTAN 80 MG per TAB